The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Drug‐resistant malaria: Molecular mechanisms and implications for public health
Open accessAbstract
Resistance to antimalarial drugs has often threatened malaria elimination efforts and historically has led to the short‐term resurgence of malaria incidences and deaths. With concentrated malaria eradication efforts currently underway, monitoring drug resistance in clinical settings complemented by in vitro drug susceptibility assays and analysis of resistance markers, becomes critical to the implementation of an effective antimalarial drug policy. Understanding of the factors, which lead to the development and spread of drug resistance, is necessary to design optimal prevention and treatment strategies. This review attempts to summarize the unique factors presented by malarial parasites that lead to the emergence and spread of drug resistance, and gives an overview of known resistance mechanisms to currently used antimalarial drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome sequence of the human malaria parasite Plasmodium falciparum
Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R. W., Carlton, J. M., Pain, A., Nelson, K. E., Bowman, S., et al. (2002) · Nature · doi:10.1038/nature01097 · Cited by 4,407
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Anderson, E. N. (1977) · eScholarship (California Digital Library) · Cited by 2,567
The economic and social burden of malaria
Sachs, J., & Malaney, P. (2002) · Nature · doi:10.1038/415680a · Cited by 2,248 · cited 1×
“bed nets and absenteeism from work) and the government (for vector control, health facilities, education and research) [13].”
BackgroundFidock, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00084-8 · Cited by 1,456
A Molecular Marker for Chloroquine-Resistant Falciparum Malaria
Djimdé, A., Doumbo, O. K., Cortese, J. F., Kayentao, K., Doumbo, S., Diourté, Y., Coulibaly, D., Dicko, A., Su, X.-Z., Nomura, T., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440403 · Cited by 1,010
The global distribution and population at risk of malaria: past, present, and future
Hay, S. I., Guerra, C. A., Tatem, A. J., Noor, A. M., & Snow, R. W. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01043-6 · Cited by 1,001
The neglected burden of Plasmodium vivax malaria
Mendis, K., Sina, B., Marchesini, P., & Carter, R. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.97 · Cited by 970
Plasmodium knowlesi Malaria in Humans Is Widely Distributed and Potentially Life Threatening
Cox-Singh, J., Davis, T. M. E., Lee, K.-S., Shamsul, S. S. G., Matusop, A., Ratnam, S., Rahman, H. A., Conway, D. J., & Singh, B. (2008) · Clinical Infectious Diseases · doi:10.1086/524888 · Cited by 886
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
Reed, M. B., Saliba, K. J., Caruana, S. R., Kirk, K., & Cowman, A. F. (2000) · Nature · doi:10.1038/35002615 · Cited by 866
Vivax Malaria: Neglected and Not Benign
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.79 · Cited by 838
Wellems, T. E., & Plowe, C. V. (2001) · The Journal of Infectious Diseases · doi:10.1086/322858 · Cited by 807
Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations
Sidhu, A. B. S., Verdier-Pinard, D., & Fidock, D. A. (2002) · Science · doi:10.1126/science.1074045 · Cited by 720
Levin, B. R., Perrot, V., & Walker, N. (2000) · Genetics · doi:10.1093/genetics/154.3.985 · Cited by 624
Quinoline Antimalarials Mechanisms of Action and Resistance and Prospects for New Agents
Foley, M. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00012-6 · Cited by 592
Foote, S. J., Thompson, J. K., Cowman, A. F., & Kemp, D. J. (1989) · Cell · doi:10.1016/0092-8674(89)90330-9 · Cited by 573
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
Eastman, R. T., & Fidock, D. A. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2239 · Cited by 568
Self-citationCowman, A. F., Morry, M. J., Biggs, B. A., Cross, G. A., & Foote, S. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9109 · Cited by 526
The public health impact of chloroquine resistance in Africa
Trape, J. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.12 · Cited by 521
Chan, M. (2010) · Cited by 514
Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum
Painter, H. J., Morrisey, J. M., Mather, M. W., & Vaidya, A. B. (2007) · Nature · doi:10.1038/nature05572 · Cited by 512
Thiers, B. H. (2006) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70110-2 · Cited by 512
Kublin, J. G., Cortese, J. F., Njunju, E. M., G. Mukadam, R. A., Wirima, J. J., Kazembe, P. N., Djimdé, A. A., Kouriba, B., Taylor, T. E., & Plowe, C. V. (2003) · The Journal of Infectious Diseases · doi:10.1086/375419 · Cited by 508
The evolution of mutation rates: separating causes from consequences
Sniegowski, P. D., Gerrish, P. J., Johnson, T., & Shaver, A. (2000) · BioEssays · doi:10.1002/1521-1878(200012)22:12<1057::aid-bies3>3.0.co;2-w · Cited by 497
Srivastava, I. K., Rottenberg, H., & Vaidya, A. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.3961 · Cited by 434
Sidhu, A. B. S., Uhlemann, A., Valderramos, S. G., Valderramos, J., Krishna, S., & Fidock, D. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/507115 · Cited by 415
Some Lessons for the Future from the Global Malaria Eradication Programme (1955–1969)
Nájera, J. A., González-Silva, M., & Alonso, P. L. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000412 · Cited by 406 · cited 1×
“Among the reasons for the eventual halt to the eradication effort were widespread resistance to available insecticides, wars and massive population movements, difficulties in obtaining sustained funding from donor countries, the lack of community participation, and finally, the emergence of chloroquine resistant malar…”
BackgroundCowman, A. F., Galatis, D., & Thompson, J. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1143 · Cited by 401
Sisowath, C., Strömberg, J., Mårtensson, A., Msellem, M., Obondo, C., Björkman, A., & Gil, J. P. (2005) · The Journal of Infectious Diseases · doi:10.1086/427997 · Cited by 377
Sidhu, A. B. S., Gaw, S. L., & Fidock, D. A. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04729.x · Cited by 375
Korsinczky, M., Chen, N., Kotecka, B., Saul, A., Rieckmann, K., & Cheng, Q. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2100-2108.2000 · Cited by 371
Su, X.-Z., Kirkman, L. A., Fujioka, H., & Wellems, T. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80447-x · Cited by 347
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance
Price, R. N., Douglas, N. M., & Anstey, N. M. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32832f14c1 · Cited by 343
Chloroquine Transport via the Malaria Parasite’s Chloroquine Resistance Transporter
Martin, R. E., Marchetti, R. V., Cowan, A. I., Howitt, S. M., Bröer, S., & Kirk, K. (2009) · Science · doi:10.1126/science.1175667 · Cited by 331
Price, R. N., Uhlemann, A.-C., van Vugt, M., Brockman, A., Hutagalung, R., Nair, S., Nash, D., Singhasivanon, P., Anderson, T. J. C., Krishna, S., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/503423 · Cited by 317
Increased Tolerance to Artemisinin in Plasmodium falciparum Is Mediated by a Quiescence Mechanism
Witkowski, B., Lelièvre, J., López Barragán, M. J., Laurent, V., Su, X.-Z., Berry, A., & Benoit-Vical, F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01636-09 · Cited by 317
Yayon, A., Cabantchik, Z. I., & Ginsburg, H. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02195.x · Cited by 310
(1972) · Medicinal Chemistry · doi:10.1016/b978-0-12-688950-5.50009-x · Cited by 301
Contribution of the pfmdr1 gene to antimalarial drug-resistance
Duraisingh, M. T., & Cowman, A. F. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.04.008 · Cited by 300
A Mechanism for the Synergistic Antimalarial Action of Atovaquone and Proguanil
Srivastava, I. K., & Vaidya, A. B. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1334 · Cited by 299
Piperaquine: A Resurgent Antimalarial Drug
Davis, T. M. E., Hung, T.-Y., Sim, I.-K., Karunajeewa, H. A., & Ilett, K. F. (2005) · Drugs · doi:10.2165/00003495-200565010-00004 · Cited by 294
A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole.
Cowman, A. F., Karcz, S., Galatis, D., & Culvenor, J. G. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.5.1033 · Cited by 291
Systematic review of amodiaquine treatment in uncomplicated malaria
Olliaro, P., Nevill, C., LeBras, J., Ringwald, P., Mussano, P., Garner, P., & Brasseur, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)06217-4 · Cited by 283
Resistance to Antimalarials in Southeast Asia and Genetic Polymorphisms in pfmdr1
Pickard, A. L., Wongsrichanalai, C., Purfield, A., Kamwendo, D., Emery, K., Zalewski, C., Kawamoto, F., Miller, R. S., & Meshnick, S. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2418-2423.2003 · Cited by 279
Picot, S., Olliaro, P., de Monbrison, F., Bienvenu, A.-L., Price, R. N., & Ringwald, P. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-89 · Cited by 266
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
Wells, T. N. C., Burrows, J. N., & Baird, J. K. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2009.12.005 · Cited by 262
Variations in frequencies of drug resistance in Plasmodium falciparum
Rathod, P. K., McErlean, T., & Lee, P.-C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9389 · Cited by 250
Spread and evolution of Plasmodium falciparum drug resistance
Mita, T., Tanabe, K., & Kita, K. (2009) · Parasitology International · doi:10.1016/j.parint.2009.04.004 · Cited by 249
Cooper, R. A., Ferdig, M. T., Su, X.-Z., Ursos, L. M. B., Mu, J., Nomura, T., Fujioka, H., Fidock, D. A., Roepe, P. D., & Wellems, T. E. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.35 · Cited by 248
Suwanarusk, R., Russell, B., Chavchich, M., Chalfein, F., Kenangalem, E., Kosaisavee, V., Prasetyorini, B., Piera, K. A., Barends, M., Brockman, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001089 · Cited by 247
The role of anti-malarial drugs in eliminating malaria
White, N. J. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-s1-s8 · Cited by 241
Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs
Fitch, C. D. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.10.003 · Cited by 240
Sisowath, C., Petersen, I., Veiga, M. I., Mårtensson, A., Premji, Z., Björkman, A., Fidock, D. A., & Gil, J. P. (2009) · Journal of Infectious Diseases · doi:10.1086/596738 · Cited by 231
Self-citationAntimalarial Drug Toxicity: A Review
AlKadi, H. O. (2007) · Chemotherapy · doi:10.1159/000109767 · Cited by 228
Ezzet, F., Mull, R., & Karbwang, J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00830.x · Cited by 219
Glucose-6-Phosphate Dehydrogenase Deficiency and Antimalarial Drug Development
Beutler, E., Duparc, S., & _, _. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.779 · Cited by 215
Egan, T. J. (2008) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2007.11.005 · Cited by 201
Maughan, S. C., Pasternak, M., Cairns, N., Kiddle, G., Brach, T., Jarvis, R., Haas, F., Nieuwland, J., Lim, B., Müller, C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913689107 · Cited by 182
Mefloquine (WR 142,490) in the Treatment of Human Malaria
Trenholme, G. M., Williams, R. L., Desjardins, R. E., Frischer, H., Carson, P. E., Rieckmann, K. H., & Canfield, C. J. (1975) · Science · doi:10.1126/science.1105787 · Cited by 177
Barnes, D. A., Foote, S. J., Galatis, D., Kemp, D. J., & Cowman, A. F. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05378.x · Cited by 174
Hunt, P., Afonso, A., Creasey, A., Culleton, R., Sidhu, A. B. S., Logan, J., Valderramos, S. G., McNae, I., Cheesman, S., Rosario, V. D., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05753.x · Cited by 167
Exploring the folate pathway in Plasmodium falciparum
Hyde, J. E. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.04.002 · Cited by 167
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether‐lumefantrine in Africa
Sisowath, C., Ferreira, P. E., Bustamante, L. Y., Dahlström, S., Mårtensson, A., Björkman, A., Krishna, S., & Gil, J. P. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2007.01843.x · Cited by 164
Raj, D. K., Mu, J., Jiang, H., Kabát, J., Singh, S., Sullivan, M., Fay, M. P., McCutchan, T. F., & Su, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806944200 · Cited by 163
Okell, L. C., Drakeley, C. J., Ghani, A. C., Bousema, T., & Sutherland, C. J. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-125 · Cited by 162
Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum
Rohrbach, P., Sanchez, C. P., Hayton, K., Friedrich, O., Patel, J., Sidhu, A. B. S., Ferdig, M. T., Fidock, D. A., & Lanzer, M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601203 · Cited by 162
Self-citationMolecular Basis for Atovaquone Binding to the Cytochrome bc 1 Complex
Kessl, J. J., Lange, B. B., Merbitz-Zahradnik, T., Zwicker, K., Hill, P., Meunier, B., Pálsdóttir, H., Hunte, C., Meshnick, S., & Trumpower, B. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304042200 · Cited by 160
Benefits of using multiple first-line therapies against malaria
Boni, M. F., Smith, D. L., & Laxminarayan, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804628105 · Cited by 155
How much fat is necessary to optimize lumefantrine oral bioavailability?
Ashley, E. A., Stepniewska, K., Lindegårdh, N., Annerberg, A., Kham, A., Brockman, A., Singhasivanon, P., White, N. J., & Nosten, F. H. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01784.x · Cited by 153
Anderson, T., Nair, S., Nkhoma, S. C., Williams, J. T., Imwong, M., Yi, P., Socheat, D., Das, D., Chotivanich, K., Day, N., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/651562 · Cited by 145
Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivax
Russell, B., Chalfein, F., Prasetyorini, B., Kenangalem, E., Piera, K. A., Suwanarusk, R., Brockman, A., Prayoga, P., Sugiarto, P., Cheng, Q., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01334-07 · Cited by 139
Amplification ofpvmdr1Associated with Multidrug‐ResistantPlasmodium vivax
Suwanarusk, R., Chavchich, M., Russell, B., Jaidee, A., Chalfein, F., Barends, M., Prasetyorini, B., Kenangalem, E., Piera, K. A., Lek‐Uthai, U., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/592451 · Cited by 137
Pharmacokinetic Determinants of the Window of Selection for Antimalarial Drug Resistance
Stepniewska, K., & White, N. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00903-07 · Cited by 133
Zhang, J., Krugliak, M., & Ginsburg, H. (1999) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(99)00008-0 · Cited by 129
Chavchich, M., Gerena, L., Peters, J. M., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00947-09 · Cited by 125
Inhibiting Plasmodium cytochrome bc1: a complex issue
Barton, V., Fisher, N. E., Biagini, G. A., Ward, S. A., & O’Neill, P. M. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.05.005 · Cited by 124
Exploring the Contribution of Candidate Genes to Artemisinin Resistance in Plasmodium falciparum
Imwong, M., Dondorp, A. M., Nosten, F. H., Yi, P., Mungthin, M., Hanchana, S., Das, D., Phyo, A. P., Lwin, K. M., Pukrittayakamee, S., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00032-10 · Cited by 123
Hudson, A. T., Dickins, M., Ginger, C. D., et al. (1991) · PubMed · Cited by 123
Quinolines and Artemisinin: Chemistry, Biology and History
Bray, P. G., Ward, S. A., & O’Neill, P. M. (2005) · Springer eBooks · doi:10.1007/3-540-29088-5_1 · Cited by 122
The origins and spread of antimalarial drug resistance: Lessons for policy makers
Anderson, T., & Roper, C. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.04.010 · Cited by 120
Cooper, R. A., Hartwig, C. L., & Ferdig, M. T. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.04.004 · Cited by 107
Plasmodium falciparum pfmdr1 Amplification, Mefloquine Resistance, and Parasite Fitness
Preechapornkul, P., Imwong, M., Chotivanich, K., Ngum, W. P., Dondorp, A. M., Day, N., White, N. J., & Pukrittayakamee, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00241-08 · Cited by 107
Warhurst, D. C., Craig, J. C., Adagu, I. S., Guy, R. K., Madrid, P. B., & Fivelman, Q. L. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.03.011 · Cited by 105
Cooper, R. A., Lane, K. D., Deng, B., Mu, J., Patel, J. J., Wellems, T. E., Su, X., & Ferdig, M. T. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05511.x · Cited by 97
Invited review Bisquinoline antimalarials: their role in malaria chemotherapy
Raynes, K. J. (1999) · International Journal for Parasitology · doi:10.1016/s0020-7519(98)00217-3 · Cited by 93
A brief history of malaria chemotherapy
Butler, A., Khan, S. S., & Ferguson, E. (2010) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2010.216 · Cited by 79
Hughes, W. T., Kennedy, W., Shenep, J. L., et al. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/163.4.843 · Cited by 74
Artemisinin resistance on the Thai–Cambodian border
Yeung, S., Socheat, D., Moorthy, V., & MILLS, A. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61856-0 · Cited by 74
The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics
Luzzatto, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60396-0 · Cited by 72
Plasmodium falciparum Na+/H+ exchanger activity and quinine resistance
Bennett, T. N., Patel, J., Ferdig, M. T., & Roepe, P. D. (2007) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2007.01.018 · Cited by 72
Plasmodium falciparumNa+/H+Exchanger 1 Transporter Is Involved in Reduced Susceptibility to Quinine
Henry, M., Briolant, S., Zettor, A., Pelleau, S., Baragatti, M. C., Baret, E., Mosnier, J., Amalvict, R., Fusaı̈, T., Rogier, C., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01243-08 · Cited by 72
Antimalarial Multi-Drug Resistance in Asia: Mechanisms and Assessment
Uhlemann, A., & Krishna, S. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-29088-5_2 · Cited by 71
Kinetic characterization of Na+/H+ antiport of Plasmodium falciparum membrane
Bosìa, A., Ghigo, D., Turrini, F. M., Nissani, E., Pescarmona, G., & Ginsburg, H. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041540311 · Cited by 70
Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology
Wernsdorfer, W. H., & Noedl, H. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200312000-00007 · Cited by 68
Naudé, B., Brzostowski, J. A., Kimmel, A. R., & Wellems, T. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503227200 · Cited by 67
Strategies to reverse drug resistance in malaria
Egan, T. J., & Kaschula, C. H. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f1673a · Cited by 65
Peters, J. M., Chen, N., Gatton, M. L., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2435-2441.2002 · Cited by 59
Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators
Loyevsky, M., John, C. S., Dickens, B. F., Hu, V. W., Miller, J. H., & Gordeuk, V. R. (1999) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(99)00053-5 · Cited by 56
Hao, M., Zhang, R., Yang, H., Fan, Q., Su, X., Miao, J., Cui, L., & Yang, Z. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00321-10 · Cited by 55
Colbourne, M. J. (1966) · Cited by 50
Artemisinin resistance on the Thai–Cambodian border
Müller, O., Sié, A., Meissner, P. E., Schirmer, R. H., & Kouyaté, B. A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61857-2 · Cited by 50
van Es, H. H. G., Renkema, G. H., Aerts, J. M. F. G., & Schurr, E. (1994) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(94)90166-x · Cited by 49
Transmission‐Dependent Tolerance to MulticlonalPlasmodium falciparumInfection
Färnert, A., Williams, T. N., Mwangi, T., Ehlin, A., Fegan, G., Macharia, A., Lowe, B. S., Montgomery, S., & Marsh, K. (2009) · The Journal of Infectious Diseases · doi:10.1086/605652 · Cited by 47
Okombo, J., Kiara, S. M., Rono, J., Mwai, L., Pole, L., Ohuma, E. O., Borrmann, S., Ochola‐Oyier, L. I., & Nzila, A. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00325-10 · Cited by 43
Molecular genetic tools in Toxoplasma and Plasmodium: achievements and future needs
Meissner, M., Breinich, M. S., Gilson, P. R., & Crabb, B. S. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.07.006 · Cited by 42
Ménard, D., Yapou, F., Manirakiza, A., Djallé, D., Matsika-Claquin, M. D., & Talarmin, A. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.75.381 · Cited by 38
Urdaneta-Márquez, L., Plowe, C. V., Goldman, I. F., & Lal, A. A. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.61.457 · Cited by 37
Malaria in Africa : challenges for control and elimination in the 21st century
Müller, O. (2011) · Cited by 27
The myth of the virgin rape myth – Authors' reply
Murray, L. K., & Burnham, G. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61859-6 · Cited by 27
Chloroquine and primaquine: combining old drugs as a new weapon against falciparum malaria?
Egan, T. J. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.03.006 · Cited by 26
Can mutation and selection explain virulence in human P. falciparum infections?
Hastings, I. M., PAGET-MCNICOL, S., & Saul, A. J. (2004) · Malaria Journal · doi:10.1186/1475-2875-3-2 · Cited by 19
Cited by
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Choi, Y., & Yu, A.-M. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282005140214165212 · Cited by 629
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
Blasco, B., Leroy, D., & Fidock, D. A. (2017) · Nature Medicine · doi:10.1038/nm.4381 · Cited by 576
Artemisinin Action and Resistance in Plasmodium falciparum
Tilley, L., Straimer, J., Gnädig, N. F., Ralph, S. A., & Fidock, D. A. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.05.010 · Cited by 359
Birth, D., Kao, W.-C., & Hunte, C. (2014) · Nature Communications · doi:10.1038/ncomms5029 · Cited by 205
Elfawal, M. A., Towler, M. J., Reich, N. G., Weathers, P. J., & Rich, S. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413127112 · Cited by 124
Metadata
- Authors
- Petersen, I., Eastman, R., & Lanzer, M.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2011-04-23
- Volume
- 585
- Issue
- 11
- Pages
- 1551-1562
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2053732861
- Cited by
- 289
- References
- 111
- FWCI
- 26.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.